OnDemand WTP Pricing Research

Patients agree with list prices in drug ads—even if they don’t like them, survey finds | FiercePharma

Politicians, trade groups, lobbyists and even doctors have weighed in on the new Trump administration rule requiring drug list prices in TV ads. But what do patients think?

Thumbs up, mostly, according to a survey by WeGo Health. The company checked in with 550 influential patients and found the majority value drug price transparency and the new rule.

For instance, while seven in 10 of the patients, who are opinion leaders in their fields, said they don’t think pharma is transparent about drug prices, three-fourths (76%) said it’s “extremely” important to consumers. On the specific rule requiring list prices in TV ads, 81% of the patient leaders said it will help consumers “make informed decisions that minimize their out-of-pocket costs.”

Read complete article here: 

Patients agree with list prices in drug ads—even if they don’t like them, survey finds | FiercePharma.

Post a Comment

WP-SpamFree by Pole Position Marketing